7,000 Rare Diseases, 30M Americans Affected-Why Nonprofits Hold the Cure
Nonprofits are increasingly funding early-stage clinical research to bridge the “valley of death”—the funding gap between laboratory discovery and human trials. By securing Orphan Drug Designation (ODD) for rare disease ... Read More